Challenging received wisdom: Antidepressants and the placebo effect

McGill Journal of Medicine

Volumn 11, Issue 2, 2008, Pages 219-222

  Kirsch, Irving ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; IPECAC; PLACEBO;

CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INFORMATION; DRUG RESEARCH; HEALTH CARE NEED; HUMAN; NAUSEA AND VOMITING; PLACEBO EFFECT; REVIEW; TREATMENT RESPONSE;

EID: 63049111202     PISSN: 1201026X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, et al. Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration. PLoS Med 2008; 5(2): e45 doi:10.1371/journal.pmed.0050045
2. Turner, E.H. et al., Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. New England Journal of Medicine 2008; 358: 252-260.
3. Melander, H., et al., Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. British Medical Journal. 2003; 326: 1171-1173.
4. Elias, M., Study: Antidepressant barely better than placebo, in USA Today. 2002.
5. Wolf, S., Effects of suggestion and conditioning on the action of chemical agents in human subjects the pharmacology of placebos. Journal of Clinical Investigation. 1950; 29:100-109.
6. Ikemi, Y. and S. Nakagawa, A psychosomatic study of contagious dermatitis. Kyushu Journal of Medical Science. 1962; 13: 335-350.
7. Hróbjartsson, A. and P.C. Gøtzsche, An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine. 2001; 344:1594-1602.
8. Wampold, B.E., Z.E. Imel, and T. Minami, The placebo effect: "Relatively large" and "robust" enough to survive another assault. Journal of Clinical Psychology. 2007; 63(4):401-403.
9. Frank, J.D., Persuasion and healing. Revised ed. 1973, Baltimore: Johns Hopkins.
10. Teasdale, J.D., Psychological treatments for depression: How do they work? Behaviour Research and Therapy. 1985; 23:157-165.
11. Kirsch, I. and G. Sapirstein, Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention and Treatment. 1998; 1: Article 2a.
12. Kornstein, S.G., et al., Gender differences in treatment response to sertraline versus imipramine in chronic depression. American Journal of Psychiatry. 2000; 157:1445-1452.
13. Editorial, A double-edged sword. Nature Reviews Drug Discovery. 2008; 7:275.
14. Rabkin, J.G., et al., How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine. Psychiatry Research. 1986; 19:75-86.
15. Ferguson, J.M., SSRI Antidepressant Medications: Adverse Effects and Tolerability Prim Care Companion J Clin Psychiatry. 2001; 3(1):22-27.
16. Warner, C.H., et al., Antidepressant Discontinuation Syndrome. American Family Physician. 2006; 74(3):449-456.